At this time in his hospital course the patient began to demonstrate signs of engraftment, including an increased white blood cell count.
On day number 14, status post transplant, the patient became increasingly tachypneic and hypoxemic and a chest x-ray revealed pulmonary edema.
While in the ICU, the patient received high-dose steroids for possible diffuse alveolar hemorrhage, as well as out of the Intensive Care Unit on cyclosporin for potential graft-versus-host disease.
The patient received two echocardiograms which were negative for evidence of heart failure.
The differential diagnosis for these fevers was felt to include graft-versus-host disease as well as infection.
On day number 11, the patient's ciprofloxacin was discontinued as the patient had a rash and was noted to have a prior allergic reaction to fluoroquinolones.
On day number 13 status post transplant, the cefepime and metronidazole were discontinued as the patient's blood cultures and nasopharyngeal swabs did not demonstrate any evidence of infection.
On day number 14, aztreonam was initiated as the patient had a chest x-ray demonstrating interstitial infiltrates.
After transfer back to the Bone Marrow Transplant Unit, the patient remained afebrile off of these antibiotics.
BAL washings were negative for bacteria, viruses, and fungi.
The differential diagnosis in this rise was felt to include third spacing of fluids causing intravascular volume depletion (the patient had a FEna of less than 1%), as well as an adverse reaction to liposomal amphotericin B.
intake secondary to mucositis and lack of appetite.
He had a period of diarrhea which was resolved at the time of discharge.
